SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GTXi (GTXI)
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
85 11 0 GTXI
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60In light of today's EMEA warning on toremifene, does anyone who follow GTXI idos-1/22/2009
59UPDATE 1-GTx says muscle drug meets main goal of mid-stage trial Mon Oct 13, 200tnsaf-10/13/2008
58GTx Presents Bone Turnover Marker Data and Additional PSA Progression Safety Anatnsaf-9/16/2008
57GTx clinical trial cleared by safety board Memphis Business Journal Monday, Julytnsaf-7/28/2008
56GTx Announces Phase III PIN Clinical Trial Will Continue As Planned Friday May 2kenhott-5/23/2008
55[Toremifene P2B hgPIN results] >>J Urol. 2006 Sep;176(3):965-70; discussituck-4/22/2008
54Glad for you! Take what you can. The market is very stingy to go along with bekeokalani'nui-4/18/2008
53Ha, that was a nail biter! According to my streamer, it closed at $15.01. Thentuck-4/18/2008
52I wasn't exactly clear. The interim efficacy look is event driven, so the ekeokalani'nui-4/17/2008
51>>I'm sure you know, top line interim efficacy look in hgPIN is due 1Qtuck-4/17/2008
50I'm sure you know, top line interim efficacy look in hgPIN is due 1Q08. Comkeokalani'nui-4/16/2008
49GTXi presented its toremifene data yesterday, but the April options continued totuck-4/16/2008
48Toremifene works by inhibiting bone resorption. The same as the bisphosphonateskenhott-3/3/2008
47GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citratkenhott-3/3/2008
46Small success in a world of hurt. Company has not addressed your question direckeokalani'nui-2/29/2008
45Congrads! I know you have followed the company for awhile. Has the company dirkenhott-2/29/2008
44Though the hgPIN results will tell us whether Acadopene delays PrCa (possible, bkeokalani'nui-2/26/2008
43<i>For once, something mostly goes right.</i> Yes! I have just a smBiomaven-2/26/2008
42Acapodene’s ADT study - lacked statistical power: While Acapodene's reductioidos-2/26/2008
41For once, something mostly goes right. Nice to have this is the can before the keokalani'nui-2/25/2008
40GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III kenhott-2/25/2008
39>>GTx Director Sear Buys 40,000 Shares Tuesday November 27, 1:10 pm ET GTxtuck-11/29/2007
38Ostarine: LGND touts its new SARM in P1 (with TAP) for similar indications: Mestuck-10/10/2007
37>>So something about the trial's power just now dawned on Leerink?<tuck-7/18/2007
36For myself, I have a lot of BT catching up to do. I am not up to date.keokalani'nui-7/18/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News